Company profile: InGeneron
1.1 - Company Overview
Company description
- Provider of autologous, evidence-based cell therapy solutions, including the Transpose RT System to isolate regenerative cells from a patient's adipose tissue for same-day treatment of various conditions, and clinical trials evaluating such therapies for rotator cuff tendinopathy, facet joint syndrome, and wrist osteoarthritis.
Products and services
- Clinical Trials for Facet Joint Syndrome: Research-focused studies evaluating the safety and efficacy of cell therapy for treating chronic back pain associated with facet joint syndrome
- Clinical Trials for Rotator Cuff Tendinopathy: Investigational studies assessing effectiveness of autologous adipose-derived regenerative cells in treating partial thickness rotator cuff tears
- Transpose® RT System: Autologous cell therapy platform that isolates regenerative cells from a patient’s adipose tissue, enabling same-day treatment across various conditions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to InGeneron
C-Lecta
HQ: Germany
Website
- Description: Provider of enzyme engineering and bioprocess development for regulated markets, developing, manufacturing, and commercializing application-oriented enzyme variants. Offers the ENESYZ technology platform for customized enzymes and microbial production strains, enzymes for food and pharmaceutical industries, and biocatalytic products that replace complex chemical processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full C-Lecta company profile →
Accuri Cytometers
HQ: United States
Website
- Description: Provider of cost-effective flow cytometers for laboratory use, designed to deliver rapid cell-by-cell analysis while reducing barriers for researchers, including instrument cost, software complexity, and maintenance effort.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accuri Cytometers company profile →
Lino Biotech
HQ: Switzerland
Website
- Description: Provider of focal molography—an entirely new, broadly patented, label-free method for measuring molecular interactions in living cells or crude biological samples—eliminating signal disturbances due to temperature changes or non-specific binding.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lino Biotech company profile →
Biotix
HQ: United States
Website
- Description: Provider of laboratory consumables and liquid handling solutions, including pipette tips (xTIP4, uTIP, aTIP), the Ergonomix manual pipetting system with light ejection, assay and deep well plates made from medical-grade virgin polypropylene, reagent reservoirs certified free of DNase/RNase/endotoxins, OEM custom consumables design and manufacturing, and Defender face shields for splash protection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotix company profile →
DNA Genotek
HQ: Canada
Website
- Description: Provider of biological sample collection, stabilization, and preparation products for health research institutes, offering human and animal DNA/RNA collection kits, stabilization and preparation reagents, and self-collection devices for saliva, oral microbiome, and first-void urine (OMNIgene, ORAcollect, Colli-Pee), plus prepIT kits and reagents for DNA extraction and inhibitor removal for downstream assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DNA Genotek company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for InGeneron
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InGeneron
2.2 - Growth funds investing in similar companies to InGeneron
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for InGeneron
4.2 - Public trading comparable groups for InGeneron
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →